Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk
HIV drug resistance testing not a priority for resource-limited settings, trial finds
Point-of-care CD4 counts improve linkage to HIV care in Kenya
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes
Fear of stigma is prompting young South Africans to seek early HIV treatment
Avoiding false positives: rapid HIV tests vary in their accuracy, so need to be used in combination
